InvestorsHub Logo
Followers 8
Posts 649
Boards Moderated 0
Alias Born 03/17/2011

Re: marthambles post# 2622

Friday, 07/29/2022 11:44:42 AM

Friday, July 29, 2022 11:44:42 AM

Post# of 7786
Sorry, it was $ENTA not $RVNC PR.

ENTA’s PR on EDP-235 phase-1/1b data:

https://ir.enanta.com/news-releases/news-release-details/enanta-pharmaceuticals-announces-positive-data-phase-1-clinical

Based on these positive safety and PK results, ENTA is advancing the 200mg qD and 400mg qD doses (without ritonavir boosting) to phase-2, which is expected to start in 4Q22.

I haven't seen any PR explaining RVNC pullback today.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent RVNC News